Literature DB >> 19407507

Genetic, molecular and clinical features of familial isolated pituitary adenomas.

Adrian F Daly1, Maria A Tichomirowa, Albert Beckers.   

Abstract

Pituitary adenomas occur in a familial setting in about 5% of all cases, and over half of these are due to multiple endocrine neoplasia type 1 (MEN1) and Carney's complex (CNC). Non-MEN1/CNC familial pituitary tumours of all tumour phenotypes, known as familial isolated pituitary adenomas (FIPA), were first described in the late 1990s. Clinical features of FIPA differ from those of sporadic pituitary adenomas, as patients with FIPA have a younger age at diagnosis and larger tumours. About 15% of patients with FIPA have mutations in the aryl hydrocarbon receptor-interacting protein gene (AIP), which indicates that FIPA may have a diverse genetic pathophysiology. This article describes the clinical features of FIPA, the tumour pathologies found in this setting and the genetic/molecular data that have recently been reported in FIPA. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407507     DOI: 10.1159/000192448

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  9 in total

1.  Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?

Authors:  Sema Yarman; Yeliz Duvarci Ogret; Fatma Savran Oguz
Journal:  Genet Test Mol Biomarkers       Date:  2015-05-04

2.  Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways.

Authors:  Paraskevi Xekouki; Monalisa Azevedo; Constantine A Stratakis
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09-01

3.  The role of AIP mutations in pituitary adenomas: 10 years on.

Authors:  Adrian F Daly; Albert Beckers
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

Review 4.  Familial isolated pituitary adenomas: from genetics to therapy.

Authors:  Federica Guaraldi; Roberto Salvatori
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

5.  Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.

Authors:  Mutlu Niyazoglu; Muge Sayitoglu; Sinem Firtina; Esra Hatipoglu; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

6.  Prevalence of AIP mutations in a series of Turkish acromegalic patients: are synonymous AIP mutations relevant?

Authors:  Z Karaca; S Taheri; F Tanriverdi; K Unluhizarci; F Kelestimur
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

7.  Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.

Authors:  Rodrigo A Toledo; Berenice B Mendonca; Maria Candida B V Fragoso; Iberê C Soares; Madson Q Almeida; Michelle B Moraes; Delmar M Lourenço; Venâncio A F Alves; Marcello D Bronstein; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

Review 8.  The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.

Authors:  Catrin Lloyd; Ashley Grossman
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

9.  SNPs in the aryl hydrocarbon receptor-interacting protein gene associated with sporadic non-functioning pituitary adenoma.

Authors:  Yeshuai Hu; Jun Yang; Yongkai Chang; Shunchang Ma; Jianfa Qi
Journal:  Exp Ther Med       Date:  2016-01-18       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.